Clinical relevance of positively determined myositis antibodies in rheumatology: a retrospective monocentric analysis.

Autor: Schumacher F; Department of Rheumatology, Krankenhaus Porz am Rhein, Cologne, Germany. f.schumacher@khporz.de.; Faculty of Health/School of Medicine, Witten/Herdecke University, Witten, Germany. f.schumacher@khporz.de., Zimmermann M; Department of Pneumology, Kliniken der Stadt Köln, Cologne, Germany.; Faculty of Health/School of Medicine, Witten/Herdecke University, Witten, Germany., Kanbach M; Faculty of Health/School of Medicine, Witten/Herdecke University, Witten, Germany., Schulze W; Wisplinghoff Medical Laboratories, Cologne, Germany., Wollsching-Strobel M; Department of Pneumology, Kliniken der Stadt Köln, Cologne, Germany.; Faculty of Health/School of Medicine, Witten/Herdecke University, Witten, Germany., Kroppen D; Department of Pneumology, Kliniken der Stadt Köln, Cologne, Germany.; Faculty of Health/School of Medicine, Witten/Herdecke University, Witten, Germany., Stanzel SB; Department of Pneumology, Kliniken der Stadt Köln, Cologne, Germany.; Faculty of Health/School of Medicine, Witten/Herdecke University, Witten, Germany., Majorski D; Department of Pneumology, Kliniken der Stadt Köln, Cologne, Germany.; Faculty of Health/School of Medicine, Witten/Herdecke University, Witten, Germany., Windisch W; Department of Pneumology, Kliniken der Stadt Köln, Cologne, Germany.; Faculty of Health/School of Medicine, Witten/Herdecke University, Witten, Germany., Strunk J; Department of Rheumatology, Krankenhaus Porz am Rhein, Cologne, Germany., Berger M; Department of Pneumology, Kliniken der Stadt Köln, Cologne, Germany.; Faculty of Health/School of Medicine, Witten/Herdecke University, Witten, Germany.
Jazyk: angličtina
Zdroj: Arthritis research & therapy [Arthritis Res Ther] 2024 Jul 16; Vol. 26 (1), pp. 132. Date of Electronic Publication: 2024 Jul 16.
DOI: 10.1186/s13075-024-03368-9
Abstrakt: Background: The increased availability of myositis autoantibodies represents new possibilities and challenges in clinical practice (Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, de Visser M, et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017;76:1955-64. https://doi.org/10.1136/annrheumdis-2017-211468 .). The aim of this study was to perform a retrospective data analysis of patient cases with positive myositis autoantibodies to analyse their significance in routine rheumatology practice.
Methods: A monocentric analysis of all the orders used to determine myositis autoantibodies from July 2019 to May 2022 in the Department of Rheumatology, Krankenhaus Porz am Rhein, Cologne, Germany, was carried out.
Results: In the defined time interval, a total of 71,597 laboratory values for the antibodies mentioned above were obtained. A total of 238 different positive autoantibodies ​​were detected in 209 patients. Idiopathic inflammatory myopathy was diagnosed in 37 patients (18%), and inflammatory rheumatic diseases other than idiopathic inflammatory myopathy were diagnosed in 90 patients (43%). No inflammatory rheumatic disease was diagnosed in 82 patients (39%). General clusters of clinical manifestations were observed.
Conclusions: In our cohort, we were able to show that a relevant proportion of patients with positive myositis antibodies did not have idiopathic inflammatory myopathies or inflammatory rheumatic diseases. This finding indicates the importance of myositis autoantibodies in this group of patients. However, further studies on the course of symptoms and examination results in patients without inflammatory rheumatic diseases and with positive myositis antibodies are necessary.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: